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Abstract
Objectives The purpose of this pictorial review is to present
the imaging spectrum of renal oncocytomas with radiological-
pathological correlation.
Conclusion The differences in tumour cellularity (high cellu-
larity or low cellularity with abundant stroma) and
haemorrhagic/cystic change contribute to a wide spectrum of
imaging findings of renal oncocytomas. Imaging findings
substantially overlap those of common subtypes of clear cell
and non-clear cell renal cell carcinomas. Multifocal renal
oncocytomas are not rare, and making the diagnosis of
oncocytomawith concomitant renal cell carcinoma is difficult.
In addition, renal oncocytomas that demonstrate interval
growth or develop in the setting of end-stage renal disease
may be mistaken for malignancy.
Teaching Points
• High cellular components demonstrate avid arterial en-
hancement and subsequent washout.
• Low cellular components demonstrate gradual subsequent
enhancement owing to abundant stroma.
• Cystic and hemorrhagic changes may account for lesion
heterogeneity in the delayed phase.
• Multifocal oncocytomas and oncocytomas coexisting with
renal cell carcinoma are not rare.
• Renal oncocytomas may demonstrate interval growth.
Keywords Renal oncocytoma . Enhancement pattern .
Radiological-pathological correlation . Diagnostic problems
Introduction
Renal oncocytoma is a benign renal tumour, accounting for
approximately 3–7 % of all renal tumours [1]. Typical imag-
ing findings of renal oncocytoma are described as a homoge-
neous hypervascular mass with subsequent washout in the
delayed phase [2, 3] (Fig. 1). A central scar is a characteristic
finding, especially in a large oncocytoma [4]. However, such
classic imaging findings are not common [5]. In many cases,
renal oncocytomas are surgically resected because preopera-
tive imaging diagnosis is not reliable to distinguish
oncocytoma from renal cell carcinoma (RCC).
Kim et al. [6] found that segmental enhancement inversion
based on the corticomedullary and early excretory phase was a
characteristic enhancement pattern of oncocytoma (Fig. 2).
Segmental enhancement inversion is a term defined as a renal
lesion that has two distinct zones of enhancement which show
inverse patterns between the corticomedullary (30–40 s) and
early excretory (120–180 s) phases. One zone is hyper-
enhancing on the corticomedullary phase, which subsequently
becomes hypo-enhancing on the early excretory phase. The
other zone is hypo-enhancing on the corticomedullary phase
and becomes hyper-enhancing on the early excretory phase
[6, 7]. However, other studies have found it controversial
whether or not segmental enhancement inversion is character-
istic for oncocytoma [7–10]. Additionally, several studies
examining the discrimination of RCC from oncocytoma based
on the corticomedullary phase have shown inconsistent results
[2, 11–13].
Therefore, renal oncocytomas demonstrate various imag-
ing findings. Not only may the discrimination of oncocytoma
from RCC be challenging, but also the presence of
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oncocytoma with concurrent RCC may be a diagnostic prob-
lem. Although imaging findings may not reliably discriminate
oncocytoma from RCC, it is meaningful for radiologists to
understand the wide imaging spectrum of oncocytomas when
approaching the differential diagnosis of renal tumours.
The purpose of this pictorial review is to present the imag-
ing spectrum of renal oncocytomas. To aid in understanding
the imaging findings of oncocytomas, radiological-
pathological correlations are provided.
The diagnostic difficulties of discriminating renal
oncocytoma from renal cell carcinoma
Several studies examining the discrimination of clear cell
RCC from oncocytoma based on arterial enhancement have
revealed inconsistent results. For example, Gakis et al. [2] and
Bird et al. [11] described that oncocytomas demonstrated
greater enhancement than clear cell RCC in the
corticomedullary phase. On the other hand, Young et al. [12]
described that clear cell RCC demonstrated greater enhance-
ment than oncocytoma. Pierorazio et al. [13] described that
peak enhancement of clear cell RCC was seen predominantly
in the corticomedullary phase, while that of oncocytoma was
seen predominantly in the nephrographic phase (Fig. 3).
Zhang et al. [14] described that oncocytoma commonly
showed avid enhancement in the venous phase.
Furthermore, oncocytoma may present as a hypovascular
mass with gradual contrast enhancement (Fig. 4) or a persis-
tently hypovascular or cystic mass (Figs. 5 and 6). Therefore,
in oncocytoma, the degree of tumoural enhancement and the
timing of peak enhancement are variable.
Fig. 1 A 71-year-old man with classic renal oncocytoma in the left
kidney. a The corticomedullary phase of the axial T1-weighted gradient
echo (GRE) magnetic resonance (MR) image with fat saturation
demonstrates an arterially enhancing mass (arrow) with hypointense
central scar (small arrow). b The nephrographic phase demonstrates
washout with enhancing central scar. c The axial T2-weighted fast spin
echo (FSE) image with fat saturation shows the tumour to be of moderate
signal (arrow) with hyperintense central scar (small arrow). d (High
magnification) Oncocytoma, organoid pattern, tightly packed nests of
tumour cells (T) with visible capillaries in the stroma (arrow)
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Kim et al. [6] found that segmental enhancement inversion
based on the corticomedullary and early excretory phases was
a characteristic enhancement pattern of a relatively small
(<4 cm) oncocytoma. In contrast, Millet et al. [8] did not find
Fig. 2 A schema of segmental enhancement inversion and a case of a 76-
year-old woman with right renal oncocytoma demonstrating segmental
enhancement inversion. a Schema of segmental enhancement inversion.
1. A tumour shows two distinct areas of hyper-enhancement (white) and
hypo-enhancement (dark grey) on the corticomedullary phase (30–40 s).
Hyper- and hypo-enhancing areas consist of higher and lower cellularity
components, respectively. 2. On the early excretory phase (120–180 s),
the higher cellularity component becomes relatively low attenuation due
to contrast washout. The lower cellularity component becomes relatively
high attenuation due to gradual enhancement of oedematous stroma.
Therefore, contrast enhancement of these two distinct areas reverse
between the corticomedullary (1) and the early excretory (2) phases.
The peak enhancement of the oedematous stroma and the optimal
timing of segmental enhancement inversion may be variable in each
tumour. b The corticomedullary phase of the axial contrast-enhanced
(CE) computed tomography (CT) demonstrates an intensely enhancing
mass with a small central portion of low attenuation (arrow). c The low
attenuation central portion in the nephrographic phase is relatively
hyperattenuating in the corticomedullary phase (arrow); the relative
enhancement is reversed. d The delayed phase shows the mass to be
nearly homogeneous (arrow). e (Low magnification) Oncocytoma, in
addition to the tightly packed nests of tumour cells (T), less densely
arranged nests are located in an oedematous stroma (arrows)
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segmental enhancement inversion in oncocytoma or RCC,
and O’Malley et al. [9] concluded that segmental
enhancement inversion was not a common or characteristic
finding for oncocytoma. Additionally, the enhancement
Fig. 3 A 72-year-old woman with a right renal oncocytoma
demonstrating persistent enhancement in the nephrographic phase. a
The arterial phase of the axial CE-CT shows a heterogeneously
enhancing mass (arrow). b The nephrographic phase shows avid
enhancement of the mass (arrow). c The delayed phase shows the mass
to washout to homogeneously low attenuation (arrow). d (Low
magnification) Oncocytoma, equal amounts of tumour cells (T) and
stoma (S). e (High magnification) Oncocytoma, organoid pattern with
classic polygonal tumour cells with abundant granular eosinophilic
cytoplasm, uniformly round nuclei with prominent nucleoli. Abundant
small blood vessels are interposed within the stroma (arrows)
Fig. 4 A 56-year-old man with right renal oncocytoma demonstrating
hypovascularity and gradual enhancement. a Coronal reformatted image
of the corticomedullary phase of a CE-CT shows a low attenuation mass in
the lower right renal pole (arrow). bThe nephrographic phase demonstrates
patchy peripheral enhancement (small arrows). c The delayed phase shows
gradual enhancement with a small residual area of low attenuation (arrow).
d (Low magnification) Oncocytoma, a peripheral rim of tumour cells (T)
surrounds abundant oedematous stroma (S)
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pattern of RCC (clear cell RCC or chromophobe RCC) may
mimic segmental enhancement inversion [15, 16] (Fig. 7).
McGahan et al. [10] described that the most common
feature of oncocytoma (<4 cm) was a heterogeneous enhanc-
ing mass that became homogeneous on the delayed phase
(Figs. 2 and 3). Woo et al. [17] described that when segmental
enhancement inversion was inconspicuous in the early excre-
tory phase, oncocytomas might appear nearly homogeneous,
especially in the case of small oncocytomas. However, similar
finding may be seen in RCC (Fig. 8). Therefore, a
characteristic enhancement pattern for renal oncocytomas
has not been widely accepted.
Vascularity and enhancement patterns of oncocytomas are
various, and oncocytomas can present as an either homogeneous
or heterogeneous mass. Such a wide spectrum of imaging
findings substantially overlaps those of common subtypes of
RCCs. When an oncocytoma presents as a heterogeneous
hypervascular mass, it may mimic clear cell RCC [14]. When
an oncocytoma presents as a homogeneous hypovascular mass,
it may mimic chromophobe or papillary RCCs on CT (Fig. 9).
Fig. 5 A 75-year-old womanwith a right renal oncocytoma presenting as
a hypovascular mass secondary to cystic change and haemorrhage. a
Unenhanced axial CT image shows an exophytic right renal mass,
which is iso-attenuating to the normal kidney (arrow). b The
corticomedullary phase of the axial CE-CT shows the mass to be low
attenuation (arrow). c The nephrographic phase demonstrates thin
enhancing septations (small arrow). d The delayed phase shows the
mass to be heterogeneous (arrow). e (Low magnification) Oncocytoma,
cystic pattern, tumour cells predominantly arranged as cystic structures
(C) with haemorrhage (arrow).
Fig. 6 An 80-year-old woman
with a right renal oncocytoma
with cystic change. a The
corticomedullary phase of the
axial CE-CT demonstrates a small
multilocular cystic right renal
mass (arrow). b (Low
magnification) Oncocytoma,
tubulocystic pattern, tumour cells
arranged as variably-sized cysts
(C) and tubules (arrow)
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Radiological-pathological correlation of renal oncocytoma
Imaging findings and pathological correlations are
summarised in Table 1.
There are three cellular patterns of renal oncocytomas,
including organoid (Figs. 1d and 3e), tubulocystic and mixed
pattern [4]. The organoid pattern is characterised by nests of
tumour cells surrounded by a reticular framework of thin
blood vessels and stroma [4]. The tumour nests can be tightly
packed (high cellularity) or loosely arranged within an
oedematous stroma (low cellularity) [4]. The tubulocystic
pattern (Fig. 6b) is characterised by tumour cells arranged as
tubular and cystic structures separated within an oedematous
stroma (low cellularity) [4].
Abundant vascularity in the organoid pattern may account
for the arterial enhancement of oncocytomas. In the organoid
pattern, tightly packed tumour nests may explain washout
Fig. 7 A 38-year-old woman with clear cell RCC of the right kidney
mimicking segmental enhancement inversion (see Fig. 2). a The
nephrographic phase of the axial CE-CT demonstrates avid contrast
enhancement and an area of central low attenuation (arrow). b The
enhancing area in the nephrographic phase (a) washes out to low
attenuation in the delayed phase. The low attenuation area in the
nephrographic phase shows relatively high attenuation (arrow)
Fig. 8 A 51-year-old woman
with clear cell RCC of the left
kidney, showing homogeneity in
the delayed phase. a The
nephrographic phase of the axial
CE-CT demonstrates a left renal
mass consisting of two distinct
areas of relative hyper-
enhancement (arrow) and hypo-
enhancement. b In the delayed
phase, the mass becomes
homogeneous (arrow)
Fig. 9 A 64-year-old man with papillary RCC of the left kidney. The
nephrographic phase of the axial CE-CT demonstrates a homogeneously
low attenuation mass (arrow)
58 Insights Imaging (2015) 6:53–64
patterns in the venous phase owing to its high cellularity. For
example, if an oncocytoma predominantly consists of tightly
packed tumour nests, the tumour would show avid arterial
enhancement and subsequent washout in the nephrographic
phase (Fig. 1). On the other hand, the presence of abundant
Fig. 10 A 74-year-old woman with multifocal renal oncocytomas. a The
axial T2-weighted FSE MR image with fat saturation shows two
heterogeneous masses in the right kidney (arrows). The tumours consist
of a mixture of intermediate (small arrow) and high signal (asterisk)
components. b The axial diffusion weighted image (b factor=800)
shows the area of moderate signal on the T2-weighted image to be
relatively high signal (arrow), suggesting increased cellularity. c The
arterial phase of the axial T1-weighted GRE image with fat saturation
demonstrates the area of intermediate signal on the T2-weighted image to
be hypervascular (arrow). d Post-contrast coronal T1-weighted GRE
image with fat saturation shows partial enhancement in the area of
increased signal on the T2-weighted image (arrow)
Fig. 11 A 64-year-old man with bilateral multifocal oncocytomas
coexisting with papillary RCC of the right kidney. The coronal
reformatted image in the nephrographic phase of the CE-CT
demonstrates five solid masses (arrows) and one simple cyst
(asterisk). An exophytic right renal mass with relatively decreased
contrast enhancement (smaller white arrow) was found to be
papillary RCC. The four remaining enhancing masses were
oncocytomas. Note that the small tumours are homogeneous (smaller
black arrows), while the larger tumours are relatively heterogeneous
(larger white arrows)
Table 1 Imaging findings and pathological correlations
Imaging findings Pathology findings
Intense arterial enhancement
and subsequent washout
High cellularity (organoid pattern)
Segmental enhancement
inversion
Two distinct areas of high cellularity
and low cellularity (oedematous
stroma) components
Arterial enhancement that
persists in the nephrographic
phase
Mixture of organoid pattern with
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stroma (low cellularity) may explain slow or gradual enhance-
ment. If an oncocytoma contains abundant stroma, the tumour
would present as a hypovascular mass or gradually enhancing
lesion (Fig. 4). If an oncocytoma consists of two distinct
components of high and low cellularity, the tumour may
demonstrate segmental enhancement inversion (Fig. 2). In
fact, Kim et al. [6] described that early-enhancing and
delayed-enhancing components in oncocytomas (segmental
enhancement inversion) reflected areas of compactly arranged
tumour cells (high cellularity) and abundant stroma,
respectively.
The difference in the cellularity (and stroma) may influence
the degree of tumour enhancement and characteristic enhance-
ment pattern of individual oncocytomas.
The prevalence of cystic change and haemorrhage in
renal oncocytomas ranges from 5 % to 20 % [1, 18,
19]. Haemorrhage and cystic change may alter the im-
aging findings of oncocytomas to present as a hetero-
geneous mass, especially in a larger tumour [17]
(Figs. 10 and 11). In addition, partial haemorrhage and
cystic change may account for lesion heterogeneity in
the delayed phase, demonstrating a focal non-enhancing
area within the tumour.
When cystic changes and haemorrhage are extensive,
oncocytomas may present as a hypovascular mass (Fig. 5).
Oncocytomas may present as a multilocular cystic mass [20]
(Fig. 6). In addition, a rare variant of telangiectatic
oncocytoma has been reported, which is histologically
characterised by a predominance of multicystic spaces filled
with blood products [21].
Magnetic resonance imaging findings
On magnetic resonance imaging (MRI), the high cellular
component demonstrates moderate signal on T2-
weighted images and relatively high signal on
diffusion-weighted imaging (Figs. 1 and 10). High T2
signal within the tumour may reflect oedematous stro-
ma, central scar or cystic change. Dynamic contrast-
enhanced MRI findings are similar to CT; the compo-
nents of high cellularity demonstrate arterial enhance-
ment and the component of high T2 signal shows grad-
ual enhancement with partial or complete fill-in [3]
(Fig. 10). It has been reported that apparent diffusion
coefficients (ADCs) of oncocytomas were significantly
Fig. 12 A 71-year-old man with
a right renal oncocytoma with
calcification. a The axial
unenhanced CT demonstrates
calcification (arrow) within the
mass. b The coronal reformatted
image in the corticomedullary
phase shows calcification in the
central scar (arrow)
Fig. 13 A 65-year-old woman with Birt-Hogg-Dube syndrome (previous history of RCC and oncocytomas). a The axial chest CT shows a pulmonary
cyst in the left lung base (arrow). b The coronal single shot FSE T2-weighted image demonstrates multiple renal cysts. The arrow depicts post-surgical
change of previous partial nephrectomy
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higher than that of RCC [22]. However, it is question-
able whether diffusion-weighted imaging is useful in the
differential diagnosis of oncocytoma versus RCC due to
the variability of oncocytoma cellularity.
Fig. 14 A 54-year-old man with a hybrid tumour (oncocytoma
containing chromophobe RCC component) in the right kidney. a The
coronal T2-weighted single shot FSE MR image shows a right upper
renal pole mass with mixed high and intermediate signal intensity
(arrow). b The corticomedullary phase of the coronal T1-weighted
GRE image shows heterogeneous enhancement of the mass. c The axial
post-contrast T1-weighted GRE image with fat saturation shows
persistent and homogenous enhancement of the mass (arrow). This
oncocytoma also demonstrates a lobular morphology. d (Low
magnification) Hybrid tumour: upper left oncocytoma; lower right
eosinophilic variant of chromophobe renal cell carcinoma
(chromophobe RCC)
Fig. 15 A 61-year-old man with
a right renal oncocytoma
demonstrating interval growth. a
The sagittal reformatted image in
the portal venous phase of a CE-
CT demonstrates a moderately
enhancing well-circumscribed
mass in the lower right renal pole
(arrow). The mass measures
3.5 cm in long axis diameter. b
Follow-up CT 2 years after a
demonstrates interval increased
size of the mass (arrow), now
measuring 4 cm
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Other uncommon imaging manifestations
Calcification
Although the pathological literature describes calcification in
31 % of oncocytomas [1], calcification is relatively uncom-
mon on CT. Calcification is typically present within the cen-
tral scar [1, 5] (Fig. 12).
Multifocal oncocytoma
Oncocytomas are multifocal in 2.5–16% of cases and bilateral
in 4–12% [23]. Multifocal oncocytomas (Figs. 10 and 11) can
be either sporadic or associated with Birt-Hogg-Dube syn-
drome. Birt-Hogg-Dube syndrome is a rare autosomal domi-
nant disease that is characterised by cutaneous hair follicle
tumours and multiple renal tumours including RCC and
oncocytoma. Renal and pulmonary cysts are also associated
with the syndrome [24] (Fig. 13). The presence of pulmonary
cysts helps to discriminate Birt-Hogg-Dube syndrome from
von-Hippel Lindau disease [24]. Renal oncocytosis (multiple
oncocytic lesions) is a recently established disease entity
defined as diffuse replacement of the renal parenchyma by
numerous oncocytic tumours, such as hybrid tumours, chro-
mophobe RCCs, renal oncocytomas, and oncocytic renal pa-
renchyma [25]. Renal oncocytosis may occur sporadically or
may be associated with chronic renal failure and long-term
haemodialysis [25].
Oncocytoma coexisting with renal cell carcinoma
Coexisting RCC is not rare in patients with oncocytoma, and
the reported incidence is up to 10 % [26]. Coexisting RCC
may present as an incidental microscopic finding sometimes
associated with oncocytoma (hybrid tumour) (Fig. 14) or as a
separate mass in the ipsilateral or contralateral kidney [27]
(Fig. 11).
Renal oncocytomas and chromophobe RCCmay be related
entities (oncocytic lesions). These two tumours may arise
from a common precursor with the potential to differentiate
into either a benign (oncocytoma) ormalignant (chromophobe
RCC) lesion [23, 24]. Hybrid tumours consisting of
oncocytoma and chromophobe RCC components have been
described [25, 28]. The lesion heterogeneity on imaging does
not indicate the presence of chromophobe RCC and imaging
findings are not helpful for making the diagnosis of a hybrid
tumour (Fig. 14). In addition, even though metastatic
oncocytomas have been reported, they may potentially be
chromophobe RCCs misdiagnosed as oncocytomas [4, 29,
30].
Findings that may be mistaken for malignancy
Interval growth
Oncocytomas may demonstrate slow interval growth
(Fig. 15). Slight interval growth does not indicate malignancy
Fig. 16 A 75-year-old woman with a left renal oncocytoma with
perinephric fat extension. The coronal reformatted image of the portal
venous phase of CE-CT shows tumour extension into the perinephric fat
at the inferior aspect of the tumour (arrow)
Fig. 17 A 58-year-old man with a right renal oncocytoma arising from end-stage renal disease. a The portal venous phase of the axial CE-CT depicts a
well-circumscribed enhancing mass (arrow) in the mid portion of the right kidney. Note that the bilateral kidneys are atrophic. b CE-CT 9 years prior
demonstrates no evidence of a renal mass
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and the growth rate is not helpful in discriminating RCC from
oncocytoma because the growth rate of RCC is variable. The
reported mean growth rate of clear cell RCC (0.7 cm/year) is
not significantly different from that of oncocytomas (0.5 cm/
year) [31].
Extension to the perinephric fat
The extension to the perinephric fat is considered atypical for
oncocytoma [4, 29] (Fig. 16) and the clinical significance of
this imaging finding is uncertain.While radiologically evident
infiltrative growth indicates malignancy, oncocytomas typi-
cally present as a well-circumscribed or lobulated mass and
associated perinephric fat extension is typically radiologically
subtle (Fig. 16).
Oncocytoma arising in end-stage renal disease
Oncocytomas rarely develop in patients on haemodialysis
[32] (Fig. 17). However, oncocytosis (multiple oncocytic
lesions) may be associated with chronic renal failure and
long-standing haemodialysis [33]. Because the pre-operative
diagnosis of oncocytoma is difficult and the association be-
tween renal cell carcinoma and long standing dialysis is well-
known, surgical treatment is warranted if the tumour is resect-
able [32].
Conclusions
The wide spectrum of imaging findings regarding renal
oncocytomas may be explained by the differences in the
variable mixture of high-cellularity and low-cellularity com-
ponents. High cellularity may explain intense arterial en-
hancement and subsequent washout. Low cellularity with
abundant stroma may explain a lesser degree of arterial en-
hancement and gradual subsequent enhancement. Cystic
change and haemorrhage may also contribute to lesion het-
erogeneity and the lesser degree of arterial enhancement.
The presence of segmental enhancement inversion may be
suggestive of renal oncocytoma, although it can be seen in
RCC. Oncocytomas tend to become homogeneous in the
delayed phase. However, it may be more practical to consider
that a heterogeneous mass in the delayed phase is more likely
RCC because it is more common than oncocytoma. When the
imaging findings are suspicious for oncocytoma, it is still
necessary to perform biopsy because imaging findings of
RCC and oncocytoma overlap. Additionally, biopsy may
mischaracterise an RCC as an oncocytoma, and some
oncocytomas may contain RCC components (hybrid tumour).
Therefore, even though a biopsy specimen is suggestive of
oncocytoma, careful imaging follow-up or less invasive
therapeutic options such as nephron-sparing surgery,
cryoablation or radiofrequency ablation may be indicated.
Open Access This article is distributed under the terms of the Creative
Commons Attribution License which permits any use, distribution, and
reproduction in any medium, provided the original author(s) and the
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